Reports and Briefs in France

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

Treatment Algorithms: Hypertension – Multiclass combinations are common but preferences differ by market

This report provides detailed hypertension treatment paths based on a survey of 153 primary care physicians across the seven major markets, with analysis of patient potential, patient segments, prescribing patterns, and leading treatment regimens.

Published By Datamonitor
27 Mar 2012 $7600
Buy
Report
Report

Treatment Algorithms: HIV – Prescribing trends mirror guidelines but will be shaken by new pipeline drugs

This report analyzes current treatment dynamics in HIV, assessing HIV treatment options and prescribing trends across the US and five major EU markets using Datamonitor’s primary physician research of 143 infectious disease specialists.

Published By Datamonitor
03 Apr 2012 $7600
Buy
Report
Report

Treatment Algorithms: Dyslipidemia – Statin monotherapies dominate the market but uncontrolled lipid levels remain an issue

This report provides detailed dyslipidemia treatment paths based on a survey of 125 primary care physicians across the seven major markets, with analysis of patient potential, patient segments, prescribing patterns, and leading treatment regimens.

Published By Datamonitor
08 May 2012 $7600
Buy
Report
Report

Treatment Algorithms: Colon Cancer – Treatment dictated by stage, prior therapy, and reimbursement

This report provides analysis of current treatment dynamics of colon cancer. Based on Datamonitor’s survey of 126 oncologists and cancer treaters the report assesses treatment type, prescribing influences, and patient numbers across disease stages.

Published By Datamonitor
26 Apr 2012 $7600
Buy
Report
Report

Treatment Algorithms: Breast Cancer (HER2-Negative/Hormone Receptor-Positive) – Diverse drug combinations employed to overcome resistance

Analysis of current treatment dynamics of HER2-negative/hormone receptor-positive breast cancer. The report assesses uptake rates and treatment types in the seven major markets using Datamonitor’s primary physician research of 130 specialists.

Published By Datamonitor
21 Mar 2012 $7600
Buy
Report
Report

Treatment Algorithms: Alzheimer's Disease – Off-label prescribing driven by dearth of treatment options

Analysis of current treatment dynamics in Alzheimer’s disease. The report assesses patient diagnosis rates and uptake rates of approved treatments across the seven major markets using Datamonitor’s primary physician research of 133 neurologists.

Published By Datamonitor
01 Mar 2012 $7600
Buy
Report
Report

The Wellbeing Consumer Trend in Global Financial Services: Financial Stress Reduction

With a slow paced recovery consumers need to be empowered to make the hard choices and take responsibility for their own financial futures, aided by tools and guidance from FS providers.

Published By Datamonitor
24 Feb 2011 $5250
Buy
Brief
Brief

The renewable landscape: solar at the threshold

Long derided as uneconomic, the nascent solar market is gaining ground on the back of policy support.

Published By Datamonitor
21 May 2009 $2795
Buy
Report
Report

The Osteoporosis Market Outlook to 2021

New anti-bone loss drugs soon to reach the osteoporosis market - but generic entry will continue to erode its value.

Published By Datamonitor
17 Jan 2013 $4500
Buy
Report
Report

The Inflammatory Bowel Disease Market Outlook to 2021

The IBD market is set to experience considerable change over the next ten years. A number of significant new product launches will reshape the market, with sales for ulcerative colitis forecast to overtake those for Crohn's disease.

Published By Datamonitor
22 Mar 2013 $4500
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.